Rare Disease Therapeutics
Innovating in rare disease
We make a meaningful contribution to the lives of rare disease patients and their families
We champion accessibility to rare disease medicines
Helping more patients access established medicines
Bringing innovative new medicines to patients in need
Why Oranda
Uniquely Oranda
Founded on Partnership
Oranda is a company founded on partnership. We're entrepreneurial and agile, with a focus on delivering value to patients, our customers and partners.
The Oranda
Our company is named after the Oranda, a rare breed of goldfish symbolising longevity, adaptability, personal growth and the pursuit of fulfilment.
Beauty in Difference
The Oranda serves as a reminder that everyone is unique and can live positive and purposeful lives. Beauty lies in our differences.
WHAT WE DO
How We Create Access
Our Approach
We are dedicated to securing sustainable access to rare disease medicines across Europe, initially through the provision of affordable, high quality, essentially similar versions of established medicines.
Discover Our ApproachOur Focus
We are focused on identifying and addressing the needs of those living with hereditary amyloidosis, cystic fibrosis and idiopathic pulmonary fibrosis.
Explore Our FocusCollaboration
We collaborate with system stakeholders, to identifying and address access barriers to ensure our medicines reach those who may benefit from them.
Partner With UsFAQ
Common questions
Oranda is a rare disease company dedicated to improving sustainable access to established and innovative new medicines across Europe.
Our current focus is on rare cardio-respiratory conditions, specifically idiopathic pulmonary fibrosis, hereditary amyloidosis and cystic fibrosis however we are committed in addressing unmet need in rare disease and consider ourselves therapy area agnostic.
Today fewer than half of all EMA approved innovative medicines are available to rare disease patients throughout Europe, with medicine affordability remaining acritical barrier to healthcare access. Oranda is committed to addressing this access issue through the provision of affordable, high quality, essentially similar versions of established rare disease medicines on Loss of Exclusivity (LoE).
Yes, we partner with organisations that value efficiency, ethical working, and long-term patient impact. Companies benefit from our commercial flexibility and resourceful ways of working.
Oranda Therapeutics is registered in Ireland with offices at Wicklow House, Market Square, Wicklow, Co. Wicklow, A67 W589.
Visit our Contact page to reach us about our corporate strategy, investment or partnership opportunities.
Ready to Partner?
Whether you're an investor, potential partner, healthcare professional, or journalist, we'd love to hear from you.
Get in TouchOTD-NP-GBR-00001 | March 2026